Sector: health
Conviction from: NASDAQCitrini
52-week range: 67.86224.31
Revolution Medicines is a clinical-stage oncology company developing targeted therapies against RAS and related cancer-driving mutations.
5 tracked filer(s) hold this · 0 opened, 4 added, 0 trimmed in 30-SEP-2026
Aggregate 13FScore 64 — mean of 5 scored holder(s) · buyers (new/add) avg 70. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Stanley Druckenmiller / Duquesne | 91 | Added +9% | 436,287 | $89,552 | 2.0% |
| Louis Bacon / Moore | 52 | Added +4% | 85,180 | $17,484,047 | 0.3% |
| Steve Cohen / Point72 | 75 | Added +184% | 228,971 | $46,998,587 | 0.1% |
| Paul Tudor Jones / Tudor | 61 | Added +8% | 47,900 | $9,831,954 | 0.0% |
| Ancora | 42 | Holds (flat) | 20 | $4,105 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
4 disclosed trade(s) by 1 filer(s).
| Trade date | Who | Type | Amount | |
|---|
| 2026-09-22 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-08-22 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $50,001 - $100,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| Report | Date | Stance |
|---|
| #124 — State of the Themes: June 2026 | 2026-06-01 | LONG |